Abstract
A major obstacle in eradicating unresectable or disseminated tumor cells with chemotherapy is thought to be due to inherent drug resistance, which in some instances may be overcome by the use of higher doses (Hryniuk and Bush 1984). Currently available chemotherapy, however, is often associated with various toxicities, in particular, bone marrow toxicity which is limiting for many of these agents. Use of recombinant hematopoietic growth factors or cytokines has enabled a modest increase in the dose chemotherapy that is tolerated. Most commonly used cytokines are granulocyte colony—stimulating factor (G—CSF) and granulocyte macrophage colony—stimulating factor (GM—CSF). Clinical trials using interleukin—3 (IL—3) and PIXY 321 (fusion protein of GM—CSF and IL—3) did not show a significant advantage over control groups (Ellis et al. 1996; Hofstra et al. 1997). Thrombopoietin, alone or in combination with other cytokines, is currently being evaluated in clinical trials. Another means of overcoming myelosuppression is the use of autologous bone marrow or peripheral stem cell transplantation after high doses of chemotherapy. This approach is currently being used in Hodgkin’s disease, breast and ovarian carcinomas (Bierman et al. 1993; Rosti et al. 1992; Reece et al. 1992; Chopra et al. 1993; Barnett et al. 1993).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allay JA, Dumenco LL, Koc ON, Liu L, Gerson SL (1995) Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells. Blood 85:3342
Alt FW, Kellems RE, BertinoJR, Schimke RT (1978) Selective amplification of dihydrofolate reductase genes in methotrexate resistant variants of cultured murine cells. J Biol Chem 253:1357
Apperley JF, Luskey BD, Williams DA (1991) Retroviral gene transfer of human adenosine deaminase in murine hematopoietic cells. Effect of selectable marker sequences on long-term expression. Blood 78:310
Aran JM, Gottesman MM, Pastan I (1994) Drug-selected coexpression of human glucocerebroside and P-glycoprotein using a bicistronic vector. Proc Natl Acad Sci USA 91:3176
Armentano D, Yu SF, Kantoff PW, von Ruden T, Anderson WF, Gilboa E (1987) Effect on internal viral sequences on the utility of retroviral vectors. J Virol 61:1647
Banerjee D, Schweitzer BI, Volkenandt M et al (1992) Transfection with a cDNA encoding a Ser3 1 or Ser34 mutant human dihydrofolate reductase into Chinese Hamster Ovary and mouse marrow progenitor cells confers methotrexate resistance. Gene 139:269
Banerjee D, Zhao SC, Tong Y, Steinherz J, Gritsman K, Bertino JR (1994a) Transfection of a nonactive site mutant murine DHFR cDNA (the Tryptophan 15 mutant) into Chinese hamster ovary and mouse marrow progenitor cells imparts MTX resistance in vitro. Cancer Gene Ther 1:181
Banerjee D, Zhao SC, Li M-X, Schweitzer BI, Mineishi S, Bertino JR (1994b) Genetherapy utilizing drug resistance genes: a review. Stem Cells 12:378
Barnett MJ, Coppin CM, Murray N, Nevill TJ, Reece DE, Klingemann HG, Shepherd JD, Nantel SH, Sutherland HJ, Phillips GL (1993) High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumors. Br J Cancer 68:594
Becket GJ, Hayes JD (1993) Glutathione S-transferases; biomedical applications. Adv Clin Chem 30:281
Bender NU, Palmer TD, Gehnas RE, Miller AD (1987) Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J Virol 61:1639
Bertino JR (1996) Active site-directed double mutants of dihydrofolate reductase. Cancer Res 56:4142
Bierman PJ, Bagin RG, Jagannath S, Vose JM, Spitzer G, Kessinger A, Dicke KA, Armitage JO (1993) High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin’s disease: long-term follow-up in 128 patients. Ann Oncol 4:767
Blakley RL (1984) Dihydrofolate Reductase. In: Blakley RL, Benkovic SJ (eds) Folates and pterins, vol 1. Wiley, New York, pp 191–253
Bodine DM, Karlsson S, Nienhuis AW (1989) Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells. Proc Natl Acad Sci USA 86:8897
Bodine DM, McDonagh KT, Seidel NE, Nienhuis AW (1991) Survival and retrovirus infection of murine hematopoietic stem cells in vitro: effects of 5-FU and method of infection. Exp Hematol 19:206
Boise LH, Gonziaz-Garcia M, Postema CE, Ding L, Lindster T, Turka LA, Mao X, Nunez G, Thompson CB (1993) Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597–608
Bordignon C, Notarangelo LD, Nobili N, Ferrari G, Casorati G, Panina P, Mazzorari N, Maggioni D, Rossi C, Servida P, Ugazio AG, Mavillo F (1995) Gene therapy in peripheral blood lymphocytes and bone marrow for ADA immunodeficient patients. Science 270:470
Bowtell DDL, Johnson GR, Kelso A, Cory S (1987) Expression of genes transferred to hematopoietic stem cells by recombinant retroviruses. Mol Biol Med 4:229
Bowtell DDL, Cory S, Johnson GR, Gonda TJ (1988) Comparison of expression in hematopoietic cells by retroviral vectors carrying two genes. J Virol 62:2464
Brennand J, Margisos GP (1986) Reduction of the toxicity and mutagenicity of alkylating agents in mammalian cells harboring the Escherichia coli alkyl-transferase gene. Proc Natl Acad Sci USA 83:6292
Brenner MK, Rill DR, Holaday MS et al (1993) Gene marking to determine whether autologous marrow infusion restores longterm hematopoiesis in cancer patients. Lancet 342:1134
Burns JC, Friedmann T, Driever W et al (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammlian and nonmammalian cells. Proc Natl Acad Sci USA 90:8033–8037
Chatterjee S, Johnson PR, Wong KK (1992) Dual-target inhibition of HIV-1 in vitro by means of adeno-associated virus antisense vector. Science 258:1485
Chaudhary PM, Roninson IB (1991) Expression and activity of P-glycopro-tein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66:85–94
Chaudhary PM, Mechetner EB, Roninson IB (1992) Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 80:2735
Chopra R, McMillan AK, Linch DC, Yuklea S, Taghipour G, Pearse R, Patterson KG, Goldstone AH (1993) The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin’s disease. A single-center eight-year study of 155 patients. Blood 81:1137
Corey CA, DeSilva AD, Holland CA, Williams DA (1990) Serial transplataion of methotrexate resistant bone marrow; protection murine recipients from drug toxocity by progeny of transduced stem cells. Blood 76: 337
Crone T, Goodtzova K, Edara S et al (1994) Mutations in human 06 -alkylguan-ine-DNA alkyltransferase imparting resistance to 006 -benzylguanine. Cancer Res 54:6221–6227
Crone TM, Pegg AE (1993) A single amino acid change in human 06 -alkyl-guanine-DNA alkyltransferase decreasing sensitivity to inactivation by 06 -benzylguanine. Cancer Res 53:4750–4753
Dao MA, Hannum C, Nolta JA et al (1995) Flt3 ligand preserves viability of human hematopoietic stem cells during in vitro transduction (abstract). Blood 86:423
Davis BM, Koc ON, Lee KM, Reese JS, Schupp JE, Gerson SL (1996) Enrichment for BCNU and 06 -benzylguanine resistant cells after transplant of G156 A MGMT transduced bone marrow progenitors in mice (meeting abstract). Blood 88:431a
Deisseroth A, Kavanagh J, Champlin R (1994) Use of safety modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of ovarian cancer: a pilot trial. Hum Gene Ther 5:1507
Delaflor-Weiss E, Richardson C, Ward M et al (1992) Transfer and expression of the human multidrug resistance gene in mouse erythroleukemia cell. Blood 80:3106–3111
Deuchars KL, Ling V (1989) Multidrug resistance in cancer chemotherapy. Semin Oncol 16:156–165
Dick JE, Magli MC, Huszar D, Phillips RA, Bernstein A (1985) Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hematopoietic system of W[Wv mice. Cell 42:71
Dicker AP, Volkenandt M, Schweitzer BI, Banerjee D, Berlino JR (1990) Identification and characterization of a gene from the methotrexate resistant Chinese hamster overy cell line Pro-3MTXRIIL J Biol Chem 265:8317
Dolan ME, Moschel RC, Pegg AE (1990) Depletion of mammalian 06-alkyl-guanine-DNA alkyltransferase activity by 0 -benzylguanine provides a means to evaluate the role of this protein in protection against carcino-genenic and therapeutic alkylating agents. Proc Natl Acad Sci USA 87:5368–5372
Drach D, Zhao S, Drach J, Mahadevia R, Gattringer C, Huber H, Andreeff M (1992) Subpopulations of normal peripheral blood and bone marrow cens express a functional multidrug resistant phenotype. Blood 80:2729
Dumenco LL, Warman B, Hatzoglou M, Lim IK, Abboud SL, Gerson SL (1989) Increase in nitrosourea resistance in mammalian cells by retrovirally mediated gene transfer of bacterial 06-alkylguanine-DNA alkyltransferase. Cancer Res 49:6044
Dunbar CE, Cottier FM, O’Shaughnessy JA et al (1995) Retrovirally marked CD34 enriched peripheral blood and bone marrow cells constribute to long-term engraftment after autologous transplantation. Blood 85:3948
Dzierzak EA, Papayannopoulou T, Mulligan RC (1988) Lineage-specific expression of a human beta-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells. Nature 331:35–41
Ellis GK, Hutchins L, Jimenez-Martin M, Pecora AL, Barnadas A, Meisenberg B, Nabholtz JM, Cortes-Funes H, Rifkin R, Chang AYC, Garrison L, George C, Giles FJ (1996) Phase III double blind randomized study of PIXY321 versus G-CSF after CEP for breast or ovarian carcinoma (meeting abstract). Blood 88:449a
Endicott JA, Ling V (1989) The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58:137
Feng M, Jackson WH Jr, Goldman CK, Rancourt C, Wang M, Dusing SK, Siegal G, Curiel DT (1997) Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector. Nat Biotechnol 15:866–870
Flasshove M, Banerjee D, Mineishi S, Schlafstein M, Berlino JR, Moore MAS (1995) Retrovirally mediated gene transfer of a mutant human dihydrofo-late reductase (DHFR) gene into progenitors from human peripheral blood (PB). Blood 85:566
Galski H, Sullivan M, Willigham MC, Chin KV, Gottesman MM, Pastan I, Merlino GT (1989) Expression of a human multidrug resistance cDNA (MDR1) in the bone marrow of transgenic mice : resistance to daunomycin-induced leukopenia. Mol Cell Biol 9:4357
Gerson SL, Miller K, Berger NA (1985) DNA alkyltransferase activity in human myeloid cells. J Chn Invest 76:2106
Gerson S, Trey J, Miller K et al (1987) Repair of 06-alkylguanine drug DNA synthesis in murine bone marrow hematopoietic precursors. Cancer Res 47:89–95
Gerson S, Phillips W, Kastan M, Dumenco LL, Donovan C (1996) Human CD34+ hematopoietic progenitors have low, cytokine-unresponsive 06 –al-kylguanine-DNA alkyltransferase and are sensitive to 0 -benzylguanine plus BCNU. Blood 88:1649–1655
Gilboa E, Eglitis NU, Kantoff PW, Anderson WF (1986) Transfer and expression of cloned genes using retroviral vectors. Biotechniques 4:504
Gottesman MM, Pastan I (1988) The multidrug transporter, a double edged sword. J Biol Chem. 263:12163–12166
Greenbaum M, Letourneau S, Assar H, Schecter R, Batist G, Cournoyer D (1994) Retrovirus mediated gene transfer of rat glutathione S-transferase Yc confers alkylating drug resistance in NIH 3T3 fibroblast. Cancer Res 54:4442
Gros P, Neriah YB, Croop JM, Housman DE (1986a) Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 323:728–731
Gros P, Croop J, Housman D (1986b) Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47:371
Hanania EG, Deisseroth AB (1994) Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector on a mouse gene therapy model. Cancer Gene Ther 1:21
Hanenberg H, Xiao XL, Diloo D, Hashino K, Brenner MK, Kato I, Williams DA (1995) Retrovirus binds to fibronectin: implication for clinical gene therapy (meeting abstract). Stem cell gene therapy: biology and technology, Washington DC
Hesdorffer C, Antman K, Bank A et al (1994) Human MDR gene transfer in patients with advanced cancer. Hum Gene Ther 5:1151
Hesdorffer C, Ayello J, Ward M, Reiss R, Vahdat L, Fetell M, Garrett TD, Bank A, Antman K (1997) A phase I clinical trial using MDR-transduced marrow and/or peripheral blood CD34+ cells (meeting abstract). Proc ASCO 16:88a
Hickson I, Fairbarin LJ, Chinnasamy N, Dexter TM, Margison GP, Rafferty JA (1996) Protection of mammalian cells against chloroethylating agent toxicity by an 06 -benzylguanine-resistant mutant of human 06-alkylguanine-DNA alkyltransferase. Gene Ther 3:868–877
Hilton J (1984) Role of aldehyde-dehydrogenase in cyclophosphamide-resis-tant L1210 leukemia. Cancer Res 44:5156
Hirose K, Longo D, Oppenheim JJ, Matsushima K (1993) Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs and ionizing radiation. FASEB J 7:361
Hockenbery DM, Oltval ZN, Yin X-M, Milliman CL, Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241–251
Hoffman B, Leibermann DA (1994) Molecular controls of apoptosis; differentiation/growth arrest primary response genes, protooncogenes, and tumor suppressor genes as positive and negative modulators. Oncogene 9:1807–1812
Hofstra LS, Trope CG, Willemse PHB, Vindevoghel A, van den Bulche JM, Lahouseny M, Sklenar I, de Vries EGE (1997) Randomized trial of rhIL-3 versus placebo in prevention of bone marrow depression during first-line chemotherapy for ovarian carcinoma (meeting abstract). Proc ASCO 16:115a
Hryniuk W, Bush H (1984) The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 2:1281
Hsu LC, Tani K, Fuiyoshi T, Kurachi K, Yoshida A (1985) Cloning of cDNAs for human aldehyde dehydrogenases 1 and 2. Proc Natl Acad Sci USA 82:3771
Hsu LC, Chang W-C, Shibuya A, Yoshida A (1992) Human stomach aldehyde dehydrogenase cDNA and genomic cloning, primary structure, and expression in Escherichia coll. J Biol Chem 267:3030
Huang R, Olsson M, Petterson U, Totterman RH (1995) Efficient adenovirus mediated gene transduction of normal and leukemic hematopoietic cells (meeting abstract). Stem cell gene therapy: biology and technology, Washington DC, p 15
Hussaon A, Lewis D, Yu M, Melera PW (1992) Construction of a dominant selectable marker using a novel dihydrofolate reductase cDNA. Gene 112:179
Isola LM, Gordon JW (1986) Systemic resistance to methotrexate in transgenic mice carrying a mutant dihydrofolate reductase gene. Proc Natl Acad Sci USA 83:9621
Jehnek J, Kleibl K, Dexter TM, Margison GP (1988) Transfection of murine multipotent hematopoietic stem cells with an E coli DNA alkyltransferase gene confers resistance to the toxic effects of alkylating agents. Carcinogenesis 9:81
Jehnek J, Fairbarin LJ, Dexter M, Rafferty JA, Stocking C, Ostertag W, Margison GP (1996) Long-term protection of hematopoiesis against the cytotoxic effects of multiple doses of nitrosourea by retrovirus-mediated expression of human 06 -alkylguanine DNA-alkyltransferase. Blood 87:1957–1961
Kaina B, Fritz G, Mitra S, Coquerelle T (1991) Transfection and expression of human 06 –methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents. Carcinogenesis 12:1857
Kaleko M, Garcia JV, Osborne WR, Miller AD (1990) Expression of human adenosine deaminase in mice after transplantation of genetically modified bone marrow. Blood 75:1773
Kartner N, Ling V (1989) Multidrug resistance in cancer. Sci Am 260(3):44–51
Kastan MB, Schlaffer E, Russo JE, Colvin OM, Civin CL, Hilton J (1990) Direct demonstration of elevated aldehyde-dehydrogenase in human hematopoietic progenitor cells. Blood 75:1947
Kavanagh J, Hanania E, Giles R, Fu SO, Zu Z, Ellerson D, Wang T, Claxton D, Rahman Z, Berenson R, Heimfeld S, Cote R, Holzmayer T, Mechetner E, Dayne A, Andreeff M, Champlin R, Deisseroth AB (1996) Genetic modification of cells used for transplant following intensive therapy for ovarian cancer and breast cancer (meeting abstract 272a). Blood 88:
Kondo S, Yin D, Morimura T, Oda Y, Kikuchi H, Takeuchi J (1994) Transfec-tion with a bcl-2 expression vector protects transplanted bone marrow from chemotherapy induced myelosuppression. Cancer Res 54:2928
Kotin R, Sinscalco M, Samulski RJ et al (1990) Site-specific integration by adeno-associated virus. Proc Natl Acad Sci USA 87:2211
Kuroda H, Sakamaki S, Kuga T, Matsunaga T, Hirayama Y, Ohi S, Takahashi Y, Niitsu Y (1996) Transfection of glutathione-s transferase p gene into CD34+ cells confers resistance to cyclophosphamide (meeting abstract 1705). Blood 88:
Laliberte J, Momparler RL (1994) Human cytidine deaminase: purification of enzyme, cloning and expression of its complementary DNA. Cancer Res 54:5401
Li MX, Banerjee D, Mineishi S, Gilboa E, Bettino JR (1994) Development of a retroviral construct containing a human mutated dihydrofolate reductase cDNA for hematopoietic stem cell transduction. Blood 83:3403
Li MX, Banerjee D, Zhao SC, et al. (1994) Development of a retroviral construct containing a human mutated dihydrofolate reductase cDNA for hematopoietic stem cell transduction. Blood 83:3403
Licht T, Aran JM, Goldenberg SK, Vieira WD, Gottesman MM, Pastan I (1995) Cytotoxic drug selection of murine bone marrow cells following transfer of the MDR1 gene increases gene expression and chemoresistance in vivo. Meeting abst. Blood 86:A960
Ludlum DB, Mehta JR, Tong WP (1986) Prevention of I-(3-deoxycytytidyl), 2–l–deoxyguanosinyl) ethane cross-link formation in DNA by rat liver 06-alkylguanine-DNA alkytransferase. Cancer Res 46:3353
Magni M, Shammah S, Schiro R, Mellado W, Dalla-Favera R, Gianni AM (1996) Induction of cyclophosphamide-resistance by aldehyde-denydro-genase gene transfer. Blood 87:1097
Markowitz D, Goff S, Bank A (1988a) Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167:400
Markowitz D, Goff S, Bank A (1988b) A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 62:1120
May C, Gunther R, McIver RS (1995) Protection of mice from lethal doses of methotrexate by transplantation with transgenic marrow expressing drug-resistant dihydrofolate reductase activity. Blood 86:2439–2448
McGown AT, Fox BW (1986) A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitro. Cancer Chemother Pharmacol 17:223
Mclvor RS, Simonsen CC (1991) Isolation and characterization of a variant dihydrofolate reductase cDNA from methotrexate resistant murine L5178Y cells. Nucleic Acids Res 18:7025
McLachlin JR, Eglitis MA, Ueda K, Kantoff PW, Pastan IH, Anderson WF, Gottesman MM (1990) Expression of a human complementary DNA for the multidrug resistance gene in murine hematopoietic precursor cells with the use of retroviral gene transfer. J Natl Cancer Inst 82:1260
Mivashita T, Reed JC (1992) Bcl-2 gene transfer increases relative resistance of S49. 1 and WEHI 7. 2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res 52:5407–5411
Miyashita T, Reed JC (1993) Bcl-2 oncoprotein blocks chemotherapy induced apoptosis in a human leukemia cell line. Blood 81:151–157
Momparler RL, Ehopoulos N, Bovenzi V, Letourneau S, Greenbaum M, Cournoyer D (1996) Resistance to cytosine arabinoside by retrovirany mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells. Cancer Gene Ther 3:331
Moore KA, Deisseroth AB, Reading CL, Williams DE, Belmont JW (1992) Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells. Blood 79:1393
Moore MAS (1995) Hematopoietic reconstruction: New approaches. Clin Cancer Res 1:3–9
Moore MAS, Hoskins I (1994) Ex vivo expansion of cord blood-derived stem cells and progenitors. Blood cells 20:468
Moore MAS, Leonard JP, Flasshove M, Bertino J, Gallardo H, Sadelain M (1996) Review: gene therapy—the challenge for the future. Ann Oncol 7:53
Moreb J, Schweder M, Suresh A, Zucah J (1996) Overexpression of the human aldehyde dehydrgenase class I results in increased resistance to 4-hydroper-oxycyclophosphamide. Cancer Gene Ther 3:24
Moritz T, Mackay W, Glassner BJ, Williams DA, Samson L (1995) Retrovirus mediated expression of a DNA repair protein in bone marrow protects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo. Cancer Res 55:2608
Nakahara S, Takebe N, Mineishi S, Zhao SC, Erickan-Abali E, Banerjee D, Sadelain M, Moore MAS, Bertino JR (1997) MFG-based retroviral vectors carrying human DHFR mutants confer higher resistance to MTX than N2-based double copy vectors in hematopoietic cells, meeting abstract. Proc Am Assoc Cancer Res 38:384
Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma I, Trono D (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263
Naumovski L, Cleary ML (1994) Bcl-2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells. Blood 83:2261–2267
Neff T, Blau A (1996) Forced expression of cytidine deaminase confers resistance to cytosine arabinoside and gemcitabine. Exp Hematol 24:1340
Nolta JA, Seader LS, Barranger JA, Kohn DB (1990) Expression of human glucocerebrosidase in murine long-term bone marrow cultures after retroviral vector-mediated transfer. Blood 75:787
Ogawa M (1989) Effects of hematopoietic growth factors on stem cells in vitro. Hematol Oncol Clin North Am 3:453
Oltvai ZN, MilliLman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog Bax, that accelerates programmed cell death. Cell 74:609–619
O’Shaughessy J, Cowan K, Nienhuis A (1994) Retroviral mediated transfer of the human multidrug resistance gene (MDR-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancer. Hum Gene Ther 5:891
Pastan I, Gottesman MM (1987) Multidrug resistance in human cancer. N Engl J Med 316:1388–1393
Pastan I, Gottesman MM (1991) Multidrug resistance. Annu Rev Med 42:277
Pegg A (1984) Methylation of the 06-position of guanine in DNA is the most likely initiating event in carcinogenesis by methylating agents. Cancer Invest 2:223–231
Pegg A (1990) Mammalian 0 -alkylguanine-DNA alkyltransferase. Regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res 50:6119–6129
Pegg AE, Weist L, Foote R et al (1983) Purification and properties of 06-methylguanine-DNA methyltransferase from rat liver. J Biol Chem 258:2327–2333
Pizzorno G, Chang YM, McGuire JJ, Bertino JR (1989) Inherent resistance of human squamous carcinoma cell lines to MTX as a result of decreased polyglutamylation of this drug Cancer Res 49:5275
Podda S, Ward M, Himelstein A, Richardson C, de la Flor-Weiss E, Smith L, Gottesman M, Pastan I, Bank A (1992) Transfer and expression of the human multiple drug resistance gene into live mice. Proc Natl Acad Sci USA 89:9676
Reece DE, Connors JM, Spinelli JJ, Barnett MJ, Fairey RN, Klingemann HG, Nantel SH, O’Reilly S, Shepherd JD, Sutherland HJ et al (1994) Intensive therapy with cyclophosphamide, carmustine, etoposide+/- cisplatin, and autologous bone marrow transplantation for Hodgkin’s disease in first relapse after combination chemotherapy. Blood 83:1193
Reed JC, Tsujimoto Y, Epstein SF, Cuddy M, Slablak T, Nowell PC, Croce CM (1989) Regulation of bcl-2 gene expression in lymphoid cell lines containing normal no 18 or t(14: 18) chromosomes. Oncogene Res 4:271–282
Rekha GK, Sreerama L, Sladek NE (1994) Intrinsic cellular resistance to oxazaphosphorines exhibited by a human colon carcinoma cell line expressing relatively large amounts of a class-3 aldehyde dehydrogenase. Biochem Pharmacol 48:1943
Richardson C, Bank A (1995) Preselection of transduced murine hematopoietic stem cell populations leads to increased long-term stability and expression of the human multiple drug resistance gene. Blood 86:2579
Roninson IB, Chin JE, Choi KG, Gros P, Housman DE, Fojo A, Shen DW, Gottesman MM, Pastan I (1986) Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 83:4538
Rosti G, Albertazzi L, Salvioni R, Pizzocaro G, Cetto GL, Bassetto NU, Marangolo M (1992) High dose chemotherapy supported with autologous bone marrow transplantation (ABMT) in germ cell tumors: a phase two study. Ann Oncol 3:809
Russo JE, Hilton J (1988) Characterization of cytosolic aldehyde-denydro-genase from cyclophosphamide resistant L1210 cells. Cancer Res 48:2963
Schweitzer BI, Srimatkadada S, Gritsman H, Sheridan R, Venkataraghavan R, Bertino JR (1989) Probing the role of two hydrophobic active site residues in dihydrofolate reductase by site directed mutagenesis. J Biol Chem 264:20786
Sha AJ, Smogorzewska EM, Hannum C et al (1995) FLT3 ligand(FL) is a potent inducer of proliferation of highly quiescent human bone marrow CD34+ CD38- cells. Blood 86:423 (abstract)
Simonsen CC, Levinsos AD (1983) Isolation and expression of an altered mouse dihydrofolate reductase cDNA. Proc Natl Acad Sci USA 80:2495
Sorrentino BP, Brandt SJ, Bodine D, Gottesman M, Pastan I, Cline A, Nien-huis AW (1992) Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 257:99
Sorrentino BP, McDonagh KT, Woods D et al (1995) Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice. Blood 86:491–501
Spencer HT, Sleep SEH, Rehg JE, Blakley RL, Sorrentino BP (1996) A gene transfer strategy for making bone marrow cells resistant to trimetrexate. Blood 87:2579
Sreerama L, Sladek NE (1994) Identification of a methylcholanthrene-induced aldehyde dehydrogenase in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific aquired resistance. Cancer Res 54:2176
Stiff PJ, Oldenberg D, Hsi E, Chen B, Douvile J, Burhop S, Bayer R, Peace D, Malhotra D, Kerger C, Armstrong D, Muller T (1997) Successful hematopoietic engraftment following high-dose chemotherapy using only ex vivo expanded bone marrow grown in Aastrom (stromal-based) bioreactors. meeting abstract. Proc Am Soc Clin Oncol 16:88a
Tano K, Shiota S, Collier J, Foote RS, Mitra S (1990) Isolation and structural characterization of a CDNA clone encoding the human DNA repair protein for 06 -alkylguanine. Proc Natl Acad Sci USA 87:686–690
Tew KD (1994) Glutathione associated enzymes in anticancer drug resistance. Cancer Res 54:4313
Tong W, Kirk M, Ludlum D (1982) Formation of the cross-link l-[N3-deoxy-cyctidyl], 2-[NI-deoxyguanosinyl]-ethane in DNA treated with N, NI-bis(2-chloroethyl)-N-nitrosourea. Cancer Res 42:3102–3105
Tsujimoto Y, Cossman J, Jaffe B, Croce CM (1985) Involvement of the bcl-2 gene in human follicular lymphoma. Science 228:40
Veeis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ (1993) Bcl-2 deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229
von Eitzen U, Meier-Tackmann D, Agarwal DP, Goedde HW (1994) Detoxification of cyclophosphamide by human aldehyde dehydrogenase isozymes. Cancer Lett 76:45
Walker S, Sofia M, Kakarla R, Kogan N, Wierichs L, Longley CB, Bruker K, Axelrod HR, Midha S, Babu S, Kahne D (1996) Cationic facial am-phiphiles: a promising class of transfection agents. Proc Natl Acad Sci USA 93:1585
Ward M, Richardson C, Pioli P et al (1994) Transfer and expression of the human multiple drug resistance gene in human CD34+ cells. Blood 84:1408–1414
Williams DA, Hsieh K, DeSilva A, Mulligan RC (1987) Protection of bone marrow transplant recipients from lethal doses methotrexate by the generation of methotrexate resistant bone marrow. J Exp Med 166:21
Wilson JM, Danos O, Grossman M, Raulet DH, Mulligan RC (1990) Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hematopoietic stem cells. Proc Natl Acad Sci USA 87:439
Wong GHW, Elwell JH, Oberly LW, Goeddel DV (1989) Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58:923
Yoshida A, Dave V, Han H, Scalon KJ (1993) Enhanced transcription of the cytosolic ALDH gene in cyclophosphamide resistant human carcinoma cells. Enzymol Mol Biol Carb Metab 4:63
Zhao SC, Li MX, Banerjee D, Mineishi S, Gilboa E, Bertino JR (1994) Long-term protection of recipient mice from lethal doses of methotrexate by marrow infected with a double copy vector retrovirus confining a mutant dihy-drofolate reductase. Cancer Gene Ther 1:27
Zhao SC, Banerjee D, Mineishi S, Bertino JR (1996) Mice bearing a transplanted mammary carcinoma tolerate curative doses of methotrexate (MTX) after transplantation with a retroviral construct containing a mutated dihydrofolate reductase (MDHFR) cDNA. AACR abstract
Zheng CF, Wang TTY, Weiner H (1993) Cloning and expression of the full-length cDNA’s encoding human liver class 1 and class 2 aldehyde dehydrogenase. Alcohol Clin Exp Res 17:828–831
Editor information
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Takebe, N., Zhao, SC., Banerjee, D., Bertino, J.R. (1998). Protection of Hematopoietic Progenitor Cells from Chemotherapy Toxicity by Transfer of Drug Resistance Genes. In: Sobol, R.E., Scanlon, K.J., Nestaas, E. (eds) Gene Therapy. Ernst Schering Research Foundation Workshop, vol 27. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-03577-1_8
Download citation
DOI: https://doi.org/10.1007/978-3-662-03577-1_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-03579-5
Online ISBN: 978-3-662-03577-1
eBook Packages: Springer Book Archive